中国消除丙型肝炎公共卫生危害行动进展、成效与挑战

李健; 刘中夫

doi:10.12449/JCH250204

中国消除丙型肝炎公共卫生危害行动进展、成效与挑战

DOI: 10.12449/JCH250204

李健,
刘中夫^, ,

中国疾病预防控制中心性病艾滋病预防控制中心，北京 102206

利益冲突声明：本文不存在任何利益冲突。

作者贡献声明：李健负责设计论文框架，起草论文，论文修改；刘中夫负责拟定写作思路，指导撰写文章并最后定稿。

详细信息

通信作者:
刘中夫， liuzhongfu@chinaaids.cn （ORCID： 0000-0002-8608-6209）

计量
- 文章访问数: 1922
- HTML全文浏览量: 57
- PDF下载量: 32
- 被引次数: 0
出版历程
- 收稿日期: 2024-12-01
- 录用日期: 2025-01-10
- 出版日期: 2025-02-25

Advances， achievements， and challenges in action to eliminate hepatitis C as a public health threat in China

Jian LI,
Zhongfu LIU^{,
,}

National Center for AIDS/STD Control and Prevention，Chinese Center for Disease Control and Prevention，Beijing 102206，China

More Information

Corresponding author: LIU Zhongfu， liuzhongfu@chinaaids.cn （ORCID： 0000-0002-8608-6209）

摘要

摘要: 自2016年世界卫生组织提出2030年消除病毒性肝炎公共卫生威胁的愿景以来，我国积极推进消除丙型肝炎危害工作，制定政策、明确主要任务、聚焦重点问题、落实防治措施，各项工作均取得了积极进展。本文回顾了2016年以来中国消除丙型肝炎危害行动进展以及所取得的工作成效，剖析目前存在的主要问题和挑战，并对未来的防治策略提出建议，旨在为实现2030年消除病毒性肝炎公共卫生威胁的目标提供参考。
- 丙型肝炎 /
- 公共卫生 /
- 疾病消除
Abstract: In 2016， the World Health Organization proposed the vision of eliminating viral hepatitis as a public health threat by 2030， and since then， China has actively promoted the elimination of hepatitis C as a public health threat and has made great achievements by formulating policies， clarifying main tasks， focusing on key issues， and implementing prevention and treatment measures. This article reviews the advances and achievements in China’s actions to eliminate hepatitis C as a public health threat since 2016， analyzes the existing problems and challenges， and puts forward recommendations for future prevention and control strategies， in order to provide a reference for achieving the goal of eliminating viral hepatitis as a public health threat by 2030.
- Hepatitis C /
- Public Health /
- Disease Eradication

HTML全文

参考文献(27)

[1]	World Health Organization. Global hepatitis report 2024: action for access in low- and middle-income countries[R/OL]. Geneva: World Health Organization, 2024. https://iris.who.int/bitstream/handle/10665/376461/9789240091672-eng.pdf?sequence=1. https://iris.who.int/bitstream/handle/10665/376461/9789240091672-eng.pdf?sequence=1
[2]	World Health Organization. Global health sector strategy on viral hepatitis 2016- 2021[EB/OL].( 2016-06)[ 2024-06-22]. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. https: //www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/
[3]	National Health Commission of the People’s Republic of China, National Development and Reform Commission, Ministry of Education, et al. Plan for the prevention and control of viral hepatitis of China(2017—2020)[J]. Chin J Virol, 2018, 8( 1): 1- 5. DOI: 10.16505/j.2095-0136.2018.0001. 国家计生卫生委, 国家发展改革委, 教育部, 等. 中国病毒性肝炎防治规划(2017—2020年)[J]. 中国病毒病杂志, 2018, 8( 1): 1- 5. DOI: 10.16505/j.2095-0136.2018.0001.
[4]	National Health Commission of the People’s Republic of China. Action plan for eliminating the public health hazard of hepatitis C( 2021— 2030)[EB/OL].( 2021-08-31)[ 2024-06-22]. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml?R0NMKk6uozOC=1654310439640. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml?R0NMKk6uozOC=1654310439640 国家卫生健康委员会. 消除丙型肝炎公共卫生危害行动工作方案( 2021— 2030 年)[EB/OL].( 2021-08-31)[ 2024-06-22]. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml?R0NMKk6uozOC=1654310439640. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml?R0NMKk6uozOC=1654310439640
[5]	General Department of the National Disease Control and Prevention Administration. Notice of the general department of the national disease control and prevention administration on carrying out the theme promotion activities for World Hepatitis Day 2023[EB/OL].( 2023-07-11)[ 2024-06-22]. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml. http: //www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml 国家疾控局综合司. 国家疾控局综合司关于做好2023年“世界肝炎日”主题宣传活动的通知[EB/OL].( 2023-07-11)[ 2024-06-22]. http://www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml. http: //www.nhc.gov.cn/jkj/s3586/202109/c462ec94e6d14d8291c5309406603153.shtml
[6]	National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention. Notice of the national AIDS/STD control and prevention center of the Chinese center for disease control and prevention on printing and distributing the core information for publicity and education on hepatitis C prevention and control(2021 version)[EB/OL].( 2021-10-28)[ 2024-06-22]. https://www.gxcdc.com/uploadfile/20220609/1654763404423432.pdf. https://www.gxcdc.com/uploadfile/20220609/1654763404423432.pdf 中国疾病预防控制中心艾防中心. 中国疾病预防控制中心艾防中心关于印发《丙肝防治宣传教育核心信息(2021版)》通知[EB/OL].( 2021-10-28)[ 2024-06-22]. https://www.gxcdc.com/uploadfile/20220609/1654763404423432.pdf. https://www.gxcdc.com/uploadfile/20220609/1654763404423432.pdf
[7]	National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention. Database of hepatitis C education materials[EB/OL].[ 2024-06-22]. https://ncaids.chinacdc.cn/zlk/bgxj/. https://ncaids.chinacdc.cn/zlk/bgxj/ 中国疾病预防控制中心艾防中心. 丙肝宣教资料库[EB/OL].[ 2024-06-22]. https://ncaids.chinacdc.cn/zlk/bgxj/. https://ncaids.chinacdc.cn/zlk/bgxj/
[8]	Branch of Nosocomial Infection Control, Chinese Preventive Medicine Association; Branch of Infectious Diseases, Chinese Medical Association; Branch of Infectious Disease Prevention and Control, Chinese Preventive Medicine Association. Chinese guideline for the prevention and control of hepatitis C virus healthcare-associated infection(2021 edition)[J]. Chin J Infec Control, 2021, 20( 6): 487- 493. DOI: 10.12138/j.issn.1671-9638.2021.06.197. 中华预防医学会医院感染控制分会, 中华医学会感染病学分会, 中华预防医学会感染性疾病防控分会. 中国丙型病毒性肝炎医院感染防控指南(2021年版)[J]. 中国感染控制杂志, 2021, 20( 6): 487- 493. DOI: 10.12138/j.issn.1671-9638.20216197.
[9]	LI J, PANG L, LI DM, et al. Hepatitis C case report and sentinel surveillance in China from 2015 to 2021[J]. Chin J AIDS STD, 2023, 29( 6): 634- 638. DOI: 10.13419/j.cnki.aids.2023.06.04. 李健, 庞琳, 李东民, 等. 2015—2021年我国丙型肝炎病例报告与哨点监测分析[J]. 中国艾滋病性病, 2023, 29( 6): 634- 638. DOI: 10.13419/j.cnki.aids.2023.06.04.
[10]	ZHAO Z, ZHANG XB, GUO Y, et al. Hepatitis C testing results among HIV key populations in Yunnan Province[J]. Chin J AIDS STD, 2024, 30( 7): 732- 735. DOI: 10.13419/j.cnki.aids.2024.07.12. 赵直, 张小斌, 郭艳, 等. 云南省艾滋病重点人群丙型肝炎检测结果分析[J]. 中国艾滋病性病, 2024, 30( 7): 732- 735. DOI: 10.13419/j.cnki.aids.2024.07.12.
[11]	LI J, LIU ZF. Handbook of hepatitis C detection strategy and technology[M]. Beijing: People’s Medical Publishing House, 2022. 李健, 刘中夫. 丙型肝炎检测策略和技术手册[M]. 北京: 人民卫生出版社, 2022.
[12]	Chinese Center for Disease Control and Prevention. China CDC Releases technical specifications for laboratory testing of hepatitis C virus(2023 Revision)[EB/OL].( 2023-10-26)[ 2024-06-22]. https://ncaids.chinacdc.cn/tzgg_10268/202310/t20231017_270150.htm. https://ncaids.chinacdc.cn/tzgg_10268/202310/t20231017_270150.htm 中国疾病预防控制中心. 中国疾病预防控制中心发布《丙型肝炎病毒实验室检测技术规范(2023年修订版)》[EB/OL].( 2023-10-26)[ 2024-06-22]. https://ncaids.chinacdc.cn/tzgg_10268/202310/t20231017_270150.htm. https://ncaids.chinacdc.cn/tzgg_10268/202310/t20231017_270150.htm
[13]	LI J, PANG L, WANG XC, et al. Progress and prospect of hepatitis C prevention and treatment in China[J]. Chin J AIDS STD, 2022, 28( 7): 761- 765. DOI: 10.13419/j.cnki.aids.2022.07.01. 李健, 庞琳, 王晓春, 等. 中国丙型肝炎防治进展与展望[J]. 中国艾滋病性病, 2022, 28( 7): 761- 765. DOI: 10.13419/j.cnki.aids.2022.07.01.
[14]	MANNS MP, BUTI M, GANE E, et al. Hepatitis C virus infection[J]. Nat Rev Dis Primers, 2017, 3: 17006. DOI: 10.1038/nrdp.2017.6.
[15]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C(2019 version)[J]. J Clin Hepatol, 2019, 35( 12): 2670- 2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008. 中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35( 12): 2670- 2686. DOI: 10.3969/j.issn.1001-5256.2019.12.008.
[16]	Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infections Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C(2022 version)[J]. Chin J Infect Dis, 2023, 41( 1): 29- 46. DOI: 10.3760/cma.j.cn311365-20230217-00045. 中华医学会肝病学分会, 中华医学会感染病学分会. 丙型肝炎防治指南(2022年版)[J]. 中华传染病杂志, 2023, 41( 1): 29- 46. DOI: 10.3760/cma.j.cn311365-20230217-00045.
[17]	LI N, LIU L, JI XY, et al. Infection status of hepatitis C cases previously reported in Henan Province from 2004 to 2021[J]. Chin J AIDS STD, 2024, 30( 7): 683- 687. DOI: 10.13419/j.cnki.aids.2024.07.03. 李宁, 刘露, 姬晓宇, 等. 河南省2004—2021年报告丙型肝炎病例感染现状分析[J]. 中国艾滋病性病, 2024, 30( 7): 683- 687. DOI: 10.13419/j.cnki.aids.2024.07.03.
[18]	LI J, YAN J, LIU ZF. Handbook of full-course management of hepatitis C cases[M]. Beijing: People’s Medical Publishing House, 2024. 李健, 严俊, 刘中夫. 丙型肝炎病例全程管理手册[M]. 北京: 人民卫生出版社, 2024.
[19]	FENG XF, DING GW, YU HL, et al. Current status of hepatitis C diagnosis and treatment in Chinese medical institutions[J]. Chin J AIDS STD, 2020, 26( 3): 247- 249. DOI: 10.13419/j.cnki.aids.2020.03.06. 冯小飞, 丁国伟, 俞海亮, 等. 医疗机构丙型肝炎诊断治疗现况研究[J]. 中国艾滋病性病, 2020, 26( 3): 247- 249. DOI: 10.13419/j.cnki.aids.2020.03.06.
[20]	DING GW, PANG L, WANG XC, et al. Analysis of baseline characteristics and treatment status of hepatitis C in sentinel hospitals from 2017 to 2019[J]. Chin J Hepatol, 2020, 28( 10): 844- 849. DOI: 10.3760/cma.j.cn501113-20200901-00492. 丁国伟, 庞琳, 王晓春, 等. 2017—2019年哨点医院丙型肝炎基线特征及治疗现况分析[J]. 中华肝脏病杂志, 2020, 28( 10): 844- 849. DOI: 10.3760/cma.j.cn501113-20200901-00492.
[21]	National Medical Products Administration, National Health Commission of the People’s Republic of China. Notice on improving the centralized purchasing of drugs negotiated by the government[EB/OL].( 2016-04-25)[ 2024-06-22]. http://www.gov.cn/xinwen/2016-05/20/content_5075022.htm. http://www.gov.cn/xinwen/2016-05/20/content_5075022.htm 国家食药监局, 国家卫生计生委员会. 关于做好国家谈判药品集中采购的通知[EB/OL].( 2016-04-25)[ 2024-06-22]. http://www.gov.cn/xinwen/2016-05/20/content_5075022.htm. http://www.gov.cn/xinwen/2016-05/20/content_5075022.htm
[22]	National Healthcare Security Administration, National Health Commission of the People’s Republic of China. Guiding opinions on establishing and improving the“dual-channel” management mechanism for negotiated drugs under the national healthcare insurance[EB/OL].( 2021-04-22)[ 2024-06-22]. https://www.gov.cn/zhengce/zhengceku/2021-05/10/content_5605595.htm. https://www.gov.cn/zhengce/zhengceku/2021-05/10/content_5605595.htm 国家医保局, 国家卫生健康委. 关于建立完善国家医保谈判药品“双通道”管理机制的指导意见[EB/OL].( 2021-04-22)[ 2024-06-22]. https://www.gov.cn/zhengce/zhengceku/2021-05/10/content_5605595.htm. https://www.gov.cn/zhengce/zhengceku/2021-05/10/content_5605595.htm
[23]	National Health and Family Planning Commission of The People’s Republic of China. WS 213-2018 Diagnosis for hepatitis C[J]. J Clin Hepatol, 2018, 34( 8): 1619- 1621. DOI: 10.3969/j.issn.1001-5256.2018.08.006. 中华人民共和国国家卫生和计划生育委员会. WS 213—2018丙型肝炎诊断[J]. 临床肝胆病杂志, 2018, 34( 8): 1619- 1621. DOI: 10.3969/j.issn.1001-5256.2018.08.006.
[24]	HEI FX, DING GW, YE SD, et al. Supervised analysis of hepatitis C virus RNA-positive case reporting in county-level hospitals-China, 2013-2018[J]. China CDC Wkly, 2020, 2( 31): 587- 590. DOI: 10.46234/ccdcw2020.157.
[25]	National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, LI J, GUO Q, et al. Hepatitis C prevention and control information system V1.0 of China’s disease control and prevention information system. Software Copyright Registration No. 12544993[Z]. 2024. 中国疾病预防控制中心性病艾滋病预防控制中心, 李健, 郭青, 等. 中国疾病预防控制信息系统丙型肝炎防治信息系统V1.0.软著登字第12544993号[Z]. 2024.
[26]	DING GW, YE SD, HEI FX, et al. Sentinel surveillance for viral hepatitis C in China, 2016-2017[J]. Chin J Epidemiol, 2019, 40( 1): 41- 45. DOI: 10.3760/cma.j.issn.0254-6450.2019.01.009. 丁国伟, 叶少东, 黑发欣, 等. 2016—2017年中国丙型肝炎哨点监测分析[J]. 中华流行病学杂志, 2019, 40( 1): 41- 45. DOI: 10.3760/cma.j.issn.0254-6450.2019.01.009.
[27]	ZHUANG H, WEI L, YANG XZ. Report on the current situation of hepatitis C infection and prevention and control strategies in China(2017)[M]. Beijing: People’s Medical Publishing House, 2018. 庄辉, 魏来, 杨希忠. 中国丙型肝炎感染现状及防治对策研究报告(2017)[M]. 北京: 人民卫生出版社, 2018.